INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

A 12-week diet with high-glucoraphanin broccoli modulated plasma metabolite profiles and interacted with PAPOLG genotype without changing CVD risk biomarkers.

Subjects were randomly assigned to consume 400 g standard broccoli, 400 g high-glucoraphanin (HG) broccoli, or 400 g peas each week for 12 weeks. No significant differences in the effects of the diets on biomarkers of CVD risk were detected. However, univariate analysis showed significant effects of sex (P < 0.001), PAPOLG genotype (P < 0.001), and PAPOLG genotype × diet (P < 0.001) on plasma metabolic profiles. In the HG broccoli arm, the intervention reduced variation between the two PAPOLG genotypes in lipid and amino acid metabolites, tricarboxylic acid (TCA) cycle intermediates, and acylcarnitines.

Study type
Randomized controlled trial
Who was studied
Human subjects randomly assigned to dietary interventions (sample size not stated)
What was measured
Biomarkers of CVD risk and 347 plasma metabolites

THE PAPER

A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function.

Armah CN, Traka MH, Dainty JR, Defernez M, Janssens A, Leung W, Doleman JF, Potter JF, Mithen RF. Am J Clin Nutr, 2013.

PubMed 23964055 ↗DOI 10.3945/ajcn.113.065235 ↗

Heart & arteriesCancerTop 21: Broccoli

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.